Normal Saline Vrs Balanced i.v. Fluids in Neurosurgery

NCT ID: NCT03429127

Last Updated: 2019-04-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-03-23

Study Completion Date

2020-02-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to investigate whether the balanced fluids therapy change plasma osmolality in neurosurgical procedures due to brain tumors, meningeomas and arterio-venous malformation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Normal saline or 0.9% sodium chloride solution is the most commonly used intravenous fluid worldwide and its composition are 154 mmol Na+ and 154 mmol Cl- per litter with osmolality of 308 mOsmol/L. That composition is not "normal" because plasma contains potassium in range between 137-146 mmol/L, and chloride in range between 98-106 mmol/L, with plasma osmolality of 280-295 mOsmol/kg. Recently published data suggested detrimental effects of chloride rich fluids on renal blood flow and glomerular filtration rate, urine output and acute kidney injury. One alternative to saline solution is a buffered, balanced, crystalloid solution with an electrolyte composition similar to plasma and osmolality between 286-295 mOsmol/L. Someone could indicate that such balanced solutions are not suitable for neurosurgical patients because of a possible impact on the brain edema development.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Benign Neoplasms Vascular Malformations, Brain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal saline fluid group

The patients in this group will receive up to 2000 ml of normal saline during neurosurgical operation.

Normal saline

Intervention Type OTHER

Plasma osmolality, acid base status and electrolytes after application up to 2000 ml of normal saline during neurosurgical operation

Balanced fluid group

The patients in this group will receive up to 2000 ml of balanced fluids during neurosurgical operation.

Balanced fluid

Intervention Type OTHER

Plasma osmolality, acid base status and electrolytes after application of up to 2000 ml balanced fluids during neurosurgical operation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Normal saline

Plasma osmolality, acid base status and electrolytes after application up to 2000 ml of normal saline during neurosurgical operation

Intervention Type OTHER

Balanced fluid

Plasma osmolality, acid base status and electrolytes after application of up to 2000 ml balanced fluids during neurosurgical operation

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

0,9 % sodium chloride Plasma-Lyte 148

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with brain tumor, meningeomas and vascular malformation.

Exclusion Criteria

* Patients with signs of elevated intracranial pressure; History of kidney disease, History of heart disease
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sisters of Mercy University Hospital

OTHER

Sponsor Role collaborator

Clinical Hospital Centre Zagreb

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Natasa Kovac

Natasa Kovac, M.D., Anesthesiologyst and intensive care medicine subspecialist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Natasa Kovac, M.D.

Role: PRINCIPAL_INVESTIGATOR

UHC Zagreb

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UHC Zgagreb

Zagreb, , Croatia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Croatia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Natasa Kovac, M.D.

Role: CONTACT

+38598296686

Inga Mladic Batinica, M.D.

Role: CONTACT

+385917811015

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Natasa Kovac, M.D.

Role: primary

+38598296686

Inga Mladic Batinica, M.D.

Role: backup

+385917811015

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

02/21 AG

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Gelaspan vs Crystalloid Therapy in Sepsis
NCT07172451 NOT_YET_RECRUITING PHASE4